INFUSYSTEM HOLDINGS, INC Current Assets
INFUSYSTEM HOLDINGS, INC (INFU) had Current Assets of $38.27 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $38.27M.
- 2026-03-31: Assets, Current $36.66M.
- 2025-12-31: Assets, Current $36.34M.
- 2025-09-30: Assets, Current $35.57M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $38.27M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $36.66M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $36.34M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $35.57M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $34.80M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $35.32M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $32.16M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $33.61M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $32.91M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $32.46M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $30.62M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $29.72M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $28.63M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $27.92M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $24.78M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $23.65M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $22.96M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $23.26M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $22.07M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $21.87M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $21.68M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $23.49M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $29.77M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $21.43M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $22.81M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $20.52M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $19.30M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $18.99M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $17.03M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $16.40M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $17.54M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $17.21M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $15.88M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $15.79M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $17.67M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $14.77M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $14.90M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $15.71M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $20.77M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $19.36M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $20.53M 10-Q/A · filed 2016-12-12 | $23.80M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $20.05M 10-Q/A · filed 2016-12-12 | $22.38M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $18.96M 10-K · filed 2017-03-22 | $20.54M 10-K · filed 2016-03-09 |
| 2015-09-30 | $18.77M 10-K/A · filed 2016-12-12 | $19.56M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $17.88M 10-K/A · filed 2016-12-12 | $18.29M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $19.91M 10-K/A · filed 2016-12-12 | $20.08M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $15.46M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $17.91M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $16.30M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $17.00M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $15.88M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $14.15M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $13.62M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $14.24M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $14.83M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $14.18M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $13.84M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $13.80M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $11.17M 10-K · filed 2013-03-28 | $13.08M 10-K · filed 2012-03-16 |
| 2011-09-30 | $12.56M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $12.04M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $15.29M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |